Antisense oligomers for treatment of conditions and diseases Grant US-11873490-B2 United States of America 16 Jan 2024
OPA1 antisense oligomers for treatment of conditions and diseases Grant US-11814622-B2 United States of America 14 Nov 2023
Modulation of gene expression and screening for deregulated protein expression Grant US-11702660-B2 United States of America 18 Jul 2023